[Congressional Record Volume 144, Number 104 (Wednesday, July 29, 1998)]
[House]
[Page H6750]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                 PASS MAMMOGRAPHY QUALITY STANDARDS ACT

  (Ms. NORTON asked and was given permission to address the House for 1 
minute and to revise and extend her remarks and include therein 
extraneous material.)
  Ms. NORTON. Mr. Speaker, great strides have been made in concurring 
breast cancer. Much of this progress is due to the work of the Congress 
in general and the bipartisan Congressional Women's Caucus in 
particular. Tamoxifen, a new drug now promises to prevent and cure 
breast cancer.
  One of the seven must-pass bills of the bipartisan Congressional 
Women's Caucus this year is the reauthorization of the Mammography 
Quality Standards Act to assure correct and safe mammograms. This bill 
has passed unanimously in the Senate. We cannot go home without doing 
the same here. American women and families deserve no less.
  Mr. Speaker, I include for the record the testimony from the Women's 
Caucus hearing on tamoxifen.

                       Introduction of Panelists

       Witness 1: Surgeon General David Satcher.
       Witness 2: Rici Rutkoss--Tamoxifen study participant.
       Witness 3: Lynda Peterson--Chair-Elect of the Susan G. 
     Komen Breast Cancer Foundation / At high risk for breast 
     cancer and considering Tamoxifen.
       Witness 4: Marica Plater--At high risk for breast cancer 
     and considering Tamoxifen.
       Witness 5: Leslie Ford, NCI Associate Director of Oncology.
       Witness 6: Dr. Michael Friedman, FDA--Acting Commissioner.
       Witness 7: Dr. Gerard Kennealey, Zeneca--Vice President of 
     Medical Affairs.

                          ____________________